EtCurae
↗Zapopan, Mexico
EtCurae is a prominent Mexican Site Management Organization (SMO) and Scientific Services Organization specializing in the management of clinical research sites, protocols, and health data. The company acts as a bridge between pharmaceutical sponsors, Contract Research Organizations (CROs), and healthcare institutions to streamline the execution of clinical trials.
The organization is particularly noted for its large-scale, long-term collaboration with the Jalisco State Government (Secretaría de Salud Jalisco), where it manages health data for clinical research and pharmacovigilance. EtCurae focuses on high-impact therapeutic areas such as metabolic syndrome, chronic-degenerative diseases, and pediatric health, leveraging digital platforms for data mining and trial management.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$10M
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Private
Total Raised:$2M+
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (Service Provider)
Modalities:Small molecule, Vaccines
Active Trials:150
Trial Phases:Phase 1: 10 | Phase 2: 40 | Phase 3: 80 | Phase 4: 20
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Secretaría de Salud Jalisco (SSJ), Avant Sante, Foundation for Biomedical Research and Innovation (FPRI), Virginia Commonwealth University (VCU) Liver Institute
COMPETITION
Position:Leader
Competitors:Novotech (Acrostar), SMO Connect, Cohortias, ClinChoice
LEADERSHIP
Key Executives:
Fernando Petersen Aranguren - Key Partner / Secretary of Health Jalisco
LINKS
Website:etcurae.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with EtCurae. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.